MAPT and Alzheimer disease: For example, African Americans with AD have lower levels of CSF tau compared to non-Hispanic Whites (NHW)6, 7, despite having equivalent levels of tau and amyloid in the brain at autopsy8, 9, and a higher lifetime incidence of dementia10–17.